| Dr Francis J Podbielski, MD | |
|
6500 Hospital Dr, Hannibal, MO 63401-6890 | |
| (573) 629-3400 | |
| (573) 629-3988 |
| Full Name | Dr Francis J Podbielski |
|---|---|
| Gender | Male |
| Speciality | General Surgery |
| Experience | 34 Years |
| Location | 6500 Hospital Dr, Hannibal, Missouri |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1740278217 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hannibal Regional Hospital | Hannibal, MO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hannibal Regional Healthcare System Inc | 1254236300 | 199 |
News Archive
Although there's "increasing pressure" on President Obama "to fill his administration's vacant top foreign-assistance post ... no candidate is in sight nine months into his term," the Associated Press writes in an article exploring the absence of a leader for USAID. Obama and Secretary of State Hillary Rodham Clinton have expressed a desire for "the agency to play a bigger role in U.S. foreign policy ... [with] more equal roles for diplomacy and development alongside defense," according to the AP.
EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today a further update regarding the status of its agreement with Merck Chimie S.A.S., one of the largest manufacturers and distributors of magnetic beads for the diagnostics market.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.
› Verified 3 days ago
| Entity Name | Hannibal Regional Healthcare System Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134311392 PECOS PAC ID: 1254236300 Enrollment ID: O20071004000422 |
News Archive
Although there's "increasing pressure" on President Obama "to fill his administration's vacant top foreign-assistance post ... no candidate is in sight nine months into his term," the Associated Press writes in an article exploring the absence of a leader for USAID. Obama and Secretary of State Hillary Rodham Clinton have expressed a desire for "the agency to play a bigger role in U.S. foreign policy ... [with] more equal roles for diplomacy and development alongside defense," according to the AP.
EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today a further update regarding the status of its agreement with Merck Chimie S.A.S., one of the largest manufacturers and distributors of magnetic beads for the diagnostics market.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Francis J Podbielski, MD Po Box 1239, Hannibal, MO 63401-1239 Ph: (573) 629-3500 | Dr Francis J Podbielski, MD 6500 Hospital Dr, Hannibal, MO 63401-6890 Ph: (573) 629-3400 |
News Archive
Although there's "increasing pressure" on President Obama "to fill his administration's vacant top foreign-assistance post ... no candidate is in sight nine months into his term," the Associated Press writes in an article exploring the absence of a leader for USAID. Obama and Secretary of State Hillary Rodham Clinton have expressed a desire for "the agency to play a bigger role in U.S. foreign policy ... [with] more equal roles for diplomacy and development alongside defense," according to the AP.
EpiCept Corporation announced today the publication of a new meta-analysis which concluded that interleukin-2 (IL-2) monotherapy is not effective as a maintenance therapy for acute myeloid leukemia (AML) patients in first complete remission. These results were published in the July 7, 2011 edition of Blood, a leading scientific journal in hematology.
CardioGenics Holdings Inc., developer of the ultra-sensitive QL Care™ Point-Of-Care analyzer and products for the immunoassay segment of the In-Vitro Diagnostics market, announced today a further update regarding the status of its agreement with Merck Chimie S.A.S., one of the largest manufacturers and distributors of magnetic beads for the diagnostics market.
The Global Fund to Fight AIDS, Tuberculosis and Malaria awarded Nigeria a $669 million Round 8 grant for health system strengthening over five years, This Day/allAfrica.com reports. "During the grant signing ceremony in Abuja yesterday, Chairman of the occasion and former Head of State, General Yakubu Gowon, disclosed that the [The Global Fund] had spent $15.6 billion in 140 countries worldwide especially in Africa to support large scale prevention treatment and care programmes against these diseases.
BioSphere Medical, Inc. – the pioneer in the use of bioengineered microspheres to treat uterine fibroids, hypervascularized tumors and vascular malformations by a minimally invasive, image-guided medical procedure called embolotherapy – reports the publication of a study in the October 2009 issue of the Journal of Vascular Interventional Radiology in which the authors conclude that uterine artery embolization (UAE) compares favorably to laparoscopic occlusion of uterine arteries in the treatment of uterine leiomyomas (fibroids) in cases where hysterectomy or myomectomy are not options.
› Verified 3 days ago